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**Abstract**

**Introduction:** Here we report a case of an 18-year-old Korean female patient with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis who developed prominent psychiatric symptoms early in the course of the disease.

**Case**: The patient was initially admitted to the department of gynecology at Ajou University Hospital for elective ovarian cystectomy. She had a 6.7cm sized mass which most likely seemed like an ovarian teratoma. However she had to be transferred to the psychiatric ward the next day, since she presented symptoms of sleep disturbance, irritable and labile mood, talkativeness, and hyperactivity which had started the day before the admission. With her prior history of a brief psychotic episode several years ago, she was treated with lithium and risperidone, under the impression of a relapsed psychiatric disease. After few days, she developed neurological symptoms such as amnesia and confusion. Neurological examination, brain MRI, and spinal tap were done, but all test results were nonspecific. Still, under the impression of anti-NMDAR encephalitis, emergent ovarian cystectomy and immunotherapy with intravenous immunoglobulin(IVIG) were done to minimize the risk of neuropsychiatric sequelae. Then her CSF anti-NMDA receptor antibody assay exhibited positive result, diagnosing her with anti-NMDAR encephalitis on her 10^th^ day of admission. She gradually recovered her alert mentality after five times of Rituximab therapy and was discharged from the hospital.

**Discussion**: Patients with anti-NMDAR encephalitis may be misdiagnosed as having a primary psychiatric disease, delaying proper diagnosis and treatment, which can result in increased risk of neuropsychiatric sequelae. This case emphasizes the need for increased awareness and diagnostic suspicion for anti-NMDAR encephalitis when approaching patients with neuropsychiatric symptoms with ovarian neoplasm, even if they have prior history and typical clinical presentation of a psychiatric disease.
